Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation

Cliff Rowe, Dave Gerrard, Roz Jenkins, Andrew Berry, Kesta Durkin, Lars Sundstrom, Chris Goldring, Kevin Park, Neil Kitteringham, Karen Piper Hanley, Neil Hanley

Hepatology; August 2013

Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?

Richard Kia, Rowena Sison-Young, James Heslop, Neil Kitteringham, Neil Hanley, John Mills, Kevin Park, Chris Goldring

British Journal of Clinical Pharmacology; April 2013

Human pluripotent stem cells for modelling toxicity

Rebecca Sison-Young, Richard Kia, James Heslop, Lorna Kelly, Cliff Rowe, M. Cross, Neil Kitteringham, Neil Hanley, Kevin Park, Chris Goldring

Advances in Pharmacology; 2012

Assessing the safety of stem cell therapeutics

Chris Goldring, Paul Duffy, Nissim Benvenisty, Peter Andrews, Uri Ben-David, Rowena Eakins, Neil French, Neil Hanley, Lorna Kelly, Neil Kitteringham, Jens Kurth, Deborah Ladenheim, Hugh Laverty, James McBlane, Gopalan Narayanan, Sara Patel, Jens Reinhardt, Annamaria Rossi, Michaela Sharpe, Kevin Park

Cell Stem Cell; June 2011

A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3

Heather Bone, Adam Nelson, Chris Goldring, David Tosh, Melanie Welham

Journal of Cell Science; June 2011

Lab-produced liver cells could improve drug testing

BBSRC Business; Summer 2011 (Page 12)

Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening

Melissa Baxter, Cliff Rowe, Jane Alder, Sean Harrison, Karen Piper Hanley, Kevin Park, Neil Kitteringham, Chris Goldring, Neil Hanley

Stem Cell Research; July 2010